LEXEO Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
Industry News
Join FA Teen Hangouts on July 13, 2024!
Ambassador
Meet the Community 2: A Closer Look – Marieke van Driel
Community
Meet the Community – Claire Juip
Community
June 2024 – Advocacy Newsletter
Advocacy
2024 Cure FA Soirée Recap
Events
C-Path Partners with FARA to Fortify RDCA-DAP and Further Accelerate Drug Development with new Friedreich’s Ataxia Data
Partner News
Meet the Community – Kyle Duhon
Community
Meet the Community – Hayden Clay Rogers
Community
Meet the Community – Anita Gracey
Community
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
Industry News
Meet the Community – Tyler Ray Rogers
Community